Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1426 - 1450 of 1485 in total
Experimental
Investigational
Tildacerfont is a corticotropin-releasing factor receptor-1 antagonist containing an unfused thiazole ring
Investigational
Rilzabrutinib is an oral, reversible covalent inhibitor of Bruton's tyrosine kinase being investigated for the treatment of immune disorders, such as immune thrombocytopenic purpura.[A259073, A259078]
Investigational
Investigational
Investigational
Tavokinogene telseplasmid consists of a DNA Plasmid Vector Encoding IL-12.
Investigational
RP-L102 is a lentiviral vector carrying the Fanconi Anemia-A (FANCA) gene currently being developed by Rocket Pharmaceuticals for the treatment of Fanconi anemia type A
Investigational
Rivabazumab pegol is being investigated as a treatment of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis.
Investigational
Displaying drugs 1426 - 1450 of 1485 in total